111 related articles for article (PubMed ID: 7756385)
1. Scientific aspects of gene therapy in melanoma.
Rankin EM
Curr Opin Oncol; 1995 Mar; 7(2):192-6. PubMed ID: 7756385
[TBL] [Abstract][Full Text] [Related]
2. Review: dendritic cell immunotherapy for melanoma.
Hadzantonis M; O'Neill H
Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-based therapy for melanoma: pre-clinical studies.
Shurin MR; Kirkwood JM; Esche C
Forum (Genova); 2000; 10(3):204-26. PubMed ID: 11007930
[TBL] [Abstract][Full Text] [Related]
5. Somatic gene therapy of human melanoma: preclinical studies and early clinical trials.
Parmiani G; Colombo MP
Melanoma Res; 1995 Oct; 5(5):295-301. PubMed ID: 8541719
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction.
Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124
[TBL] [Abstract][Full Text] [Related]
7. [Strategies for gene therapy of melanoma].
Dummer R; Davis-Daneshfar A; Döhring C; Döbbeling U; Burg G
Hautarzt; 1995 May; 46(5):305-8. PubMed ID: 7607892
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for melanoma in humans.
Gutzmer R; Guerry D
Hematol Oncol Clin North Am; 1998 Jun; 12(3):519-38. PubMed ID: 9684096
[TBL] [Abstract][Full Text] [Related]
9. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
10. Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
Smith CL; Dunbar PR; Mirza F; Palmowski MJ; Shepherd D; Gilbert SC; Coulie P; Schneider J; Hoffman E; Hawkins R; Harris AL; Cerundolo V
Int J Cancer; 2005 Jan; 113(2):259-66. PubMed ID: 15386406
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
12. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
13. New vaccine approach targets melanoma.
Schub T
Lab Anim (NY); 2004 Sep; 33(8):9. PubMed ID: 15334096
[No Abstract] [Full Text] [Related]
14. Adenovirus-mediated ex vivo immunogene and in vivo combination gene therapy strategies induce a systemic anti-tumor immune defense in the mouse B16 melanoma model.
Bonnekoh B; Greenhalgh DA; Chen SH; Bickenbach J; Block A; Rich SS; Krieg T; Woo SL; Roop DR
Adv Exp Med Biol; 1998; 451():335-43. PubMed ID: 10026893
[No Abstract] [Full Text] [Related]
15. Advances in gene therapy for malignant melanoma.
Sotomayor MG; Yu H; Antonia S; Sotomayor EM; Pardoll DM
Cancer Control; 2002; 9(1):39-48. PubMed ID: 11907465
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.
Sun Y; Jurgovsky K; Möller P; Alijagic S; Dorbic T; Georgieva J; Wittig B; Schadendorf D
Gene Ther; 1998 Apr; 5(4):481-90. PubMed ID: 9614572
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy in malignant melanoma. Interview with D. Schadendorf].
Schadendorf D
Hautarzt; 1996 Dec; 47(12):962-4. PubMed ID: 9081947
[No Abstract] [Full Text] [Related]
18. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.
Mackensen A; Meidenbauer N; Vogl S; Laumer M; Berger J; Andreesen R
J Clin Oncol; 2006 Nov; 24(31):5060-9. PubMed ID: 17075125
[TBL] [Abstract][Full Text] [Related]
19. Making It Personal: Neoantigen Vaccines in Metastatic Melanoma.
Hellmann MD; Snyder A
Immunity; 2017 Aug; 47(2):221-223. PubMed ID: 28813655
[TBL] [Abstract][Full Text] [Related]
20. Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors.
Okada Y; Okada N; Nakagawa S; Mizuguchi H; Kanehira M; Nishino N; Takahashi K; Mizuno N; Hayakawa T; Mayumi T
Cancer Lett; 2002 Mar; 177(1):57-63. PubMed ID: 11809531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
